Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000932471-25-000423·Applied Therapeutics, Inc.
Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock · CUSIP: 03828A101
Event date: 2025-03-31
- Filing-level shares
- 5,889,193
- Percent of class
- 5.06%
- The Vanguard Group
Shares: 5,889,193 · Class: 5.06%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000423
- Form type
- SCHEDULE 13G
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Apr 30, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership